Vectorology - GEG Tech top picks
23.4K views | +3 today
Vectorology - GEG Tech top picks
Your new post is loading...
Your new post is loading...
Scooped by BigField GEG Tech
April 7, 2016 2:51 AM
Scoop.it!

Construction and Identification of the RNAi Recombinant Lentiviral Vector Targeting Human DEPDC7 Gene

Construction and Identification of the RNAi Recombinant Lentiviral Vector Targeting Human DEPDC7 Gene | Vectorology - GEG Tech top picks | Scoop.it

Click here to edit the content

BigField GEG Tech's insight:

In this study, the scientists construct an RNA interference (RNAi) recombinant lentiviral vector particle targeting DEPDC7 in order to knockdown its gene expression in human hepatocellular carcinoma cell line HepG2. They observe that  migration and invasion of transduced HepG2 cells were significantly increased. These data suggest that shRNA-mediated knockdown of DEPDC7 enable promotion of cell migration and invasion.

No comment yet.
Scooped by BigField GEG Tech
April 5, 2016 2:20 AM
Scoop.it!

In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell Implants 

BigField GEG Tech's insight:

In an attempt to modulate mesenchymal stem cells (MSCs) allograft rejection in vivo, the authors transduced MSCs with an interleukin-13 (IL13)-expressing lentiviral vector. Their data clearly indicate that prolonged survival of IL13-expressing allogeneic MSC grafts in muscle tissue coincided with the induction of an alternatively activated macrophage phenotype in vivo and a reduced number of alloantigen-reactive IFNγ- and/or IL2-producing CD8+ T cells compared to nonmodified allografts. Similarly, intracerebral IL13-expressing MSC allografts also exhibited prolonged survival and induction of an alternatively activated macrophage phenotype, although a peripheral T cell component was absent. In summary, this study demonstrates that both innate and adaptive immune responses are effectively modulated in vivo by locally secreted IL13, ultimately resulting in prolonged MSC allograft survival in both muscle and brain tissue.

No comment yet.
Scooped by BigField GEG Tech
March 23, 2016 7:15 AM
Scoop.it!

Treating Immunodeficiency through HSC Gene Therapy: Trends in Molecular Medicine

Treating Immunodeficiency through HSC Gene Therapy: Trends in Molecular Medicine | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

Here, the authors review progress that has been made over the clinical trials using first-generation gamma-retroviral vectors. They talk about vectors which have since been developed, affording comparable efficacy with an improved biosafety profile. These vectors are now in Phase I/II clinical trials for a number of immune disorders with more preclinical studies underway. Targeted gene editing allowing precise DNA correction via platforms such as ZFNs, TALENs and CRISPR/Cas9 may now offer promising strategies to improve the safety and efficacy of gene therapy in the future.

No comment yet.
Scooped by BigField GEG Tech
March 18, 2016 7:31 AM
Scoop.it!

Non-integrating viral vector delivers chemotherapy-sensitizing gene to pancreatic cancer cells

Non-integrating viral vector delivers chemotherapy-sensitizing gene to pancreatic cancer cells | Vectorology - GEG Tech top picks | Scoop.it
Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy

http://online.liebertpub.com/doi/full/10.1089/hum.2015.151

BigField GEG Tech's insight:

A novel HIV-based lentiviral vector can introduce a gene to pancreatic tumor cells that makes them more sensitive to the chemotherapeutic drug gemcitabine, without integrating into cellular DNA. This integrase-defective lentiviral delivery system greatly reduces the risk of insertional mutagenesis and replication-competent lentivirus production, as describe in a new study published in Human Gene Therapy.

No comment yet.
Scooped by BigField GEG Tech
March 16, 2016 2:30 PM
Scoop.it!

Optogenetic Engineering of Atrial Cardiomyocytes 

Optogenetic Engineering of Atrial Cardiomyocytes  | Vectorology - GEG Tech top picks | Scoop.it

Click here to edit the content

BigField GEG Tech's insight:

Optogenetics is emerging in the cardiology field as a new strategy to explore biological functions through the use of light-sensitive proteins and dedicated light sources. For example, this technology allows modification of the electrophysiological properties of cardiac muscle cells with superb spatiotemporal resolution and quantitative control. In this chapter, the optogenetic modification of atrial cardiomyocytes (aCMCs) from 2-day-old Wistar rats using lentiviral vector (LV) technology and the subsequent activation of the light-sensitive proteins (i.e., ion channels) through light-emitting diodes (LEDs) are described.

No comment yet.
Scooped by BigField GEG Tech
March 11, 2016 6:25 AM
Scoop.it!

Effects of FVIII immunity on hepatocyte and hematopoietic stem cell–directed gene therapy of murine hemophilia A

Effects of FVIII immunity on hepatocyte and hematopoietic stem cell–directed gene therapy of murine hemophilia A | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

In this work, the authors investigated the ability of liver-directed AAV-FVIII gene therapy to affect FVIII immunity in hemophilia A mice. Their data suggest that functional differences exist in the immune modulation achieved to FVIII or FIX in hemophilia mice by gene therapy approaches incorporating liver-directed AAV vectors or HSC-directed LV.

No comment yet.
Scooped by BigField GEG Tech
March 8, 2016 6:33 AM
Scoop.it!

MicroRNA-338 and microRNA-21 co-transfection for the treatment of rat sciatic nerve injury 

MicroRNA-338 and microRNA-21 co-transfection for the treatment of rat sciatic nerve injury  | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

In this work, the authors injected lentiviral vectors expressing microRNA-338 and microRNA-21 in the rat spinal cord to promote functional recovery after peripheral nerve injury in rats. They observe that animals treated with microRNA-338 and microRNA-21 showed significantly better recovery than GFP control group. In conclusion lentiviral vectors encoding microRNA 338 and 21 might be explored in the future as potential therapeutic intervention to promote nerve regeneration.

 

www.geg-tech.com/Vectors

No comment yet.
Scooped by BigField GEG Tech
March 4, 2016 10:30 AM
Scoop.it!

Obstacles and future of gene therapy for hemophilia

Obstacles and future of gene therapy for hemophilia | Vectorology - GEG Tech top picks | Scoop.it
(2015). Obstacles and future of gene therapy for hemophilia. Expert Opinion on Orphan Drugs: Vol. 3, No. 9, pp. 997-1010. doi: 10.1517/21678707.2015.1069179
BigField GEG Tech's insight:

The recent success of early-phase clinical trials for adeno-associated viral (AAV) liver-directed gene therapy for hemophilia B (HB) demonstrates the potential for gene therapy, in the future, to succeed protein-based prophylaxis therapy for HB. Significant obstacles, however, need to be overcome prior to widespread adoption. This review discuss about obstacles such asimmune responses to the AAV capsid including preexisting neutralizing antibodies (NAbs) and a delayed cellular immune response.

 

www.geg-tech.com/Vectors

No comment yet.
Scooped by BigField GEG Tech
March 2, 2016 6:16 AM
Scoop.it!

Gene therapy using retrovirus vectors: vector development and biosafety at clinical trials

Gene therapy using retrovirus vectors: vector development and biosafety at clinical trials | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

Conventional gammaretroviral vectors achieved successful results in clinical trials: treated patients had therapeutic gene expression in target cells and had improved symptoms of diseases. However, serious side-effects of leukemia occurred, caused by retroviral insertional mutagenesis. The authors discuss about these results and about the design of new tools for gene therapy.

No comment yet.
Scooped by BigField GEG Tech
February 24, 2016 2:40 AM
Scoop.it!

Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 models

Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 models | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

In this study, the authos investigate about the role of ataxin-3, in Machado-Joseph disease, which causes dendritic and synapse loss in cultured neurons when expanded. 

In rats stereotaxically injected with expanded ataxin-3–encoding lentiviral vectors, mutation of serine 12 reduces aggregation, neuronal loss, and synapse loss. These results suggest that S12 plays a role in the pathogenic pathways mediated by polyglutamine-expanded ataxin-3 and that phosphorylation of this residue protects against toxicity.


www.geg-tech.com/Vectors

No comment yet.
Scooped by BigField GEG Tech
February 23, 2016 6:40 AM
Scoop.it!

Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice

Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

 In the present study, lentiviral vectors encoding Ub-HBcAg (LV-Ub-HBcAg) were designed and constructed as a therapeutic vaccine for immunotherapy. demonstrated that immunization with LV-Ub-HBcAg promoted the secretion of cytokines interleukin-2 (IL-2), interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α), generated remarkably high percentages of IFN-γ-secreting CD8+ T cells and CD4+ T cells, and enhanced HBcAg-specific CTL activity in HBV transgenic mice. The therapeutic vaccine LV-Ub-HBcAg could break immune tolerance, and induce potent HBcAg specific cellular immune responses and therapeutic effects in HBV transgenic mice.


www.geg-tech.com/Vectors

No comment yet.
Scooped by BigField GEG Tech
February 17, 2016 6:13 AM
Scoop.it!

Cell Death and Differentiation - Inflammasome-dependent IL-1[beta] release depends upon membrane permeabilisation

Cell Death and Differentiation - Inflammasome-dependent IL-1[beta] release depends upon membrane permeabilisation | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

Here the authors used a lentiviral vector which expresses pro-IL-1β as a C-terminal fluorescent Venus protein fusion to transform immortalised mouse bone marrow-derived macrophages (BMDMs) and investigate  the mechanisms of IL-1β release from macrophags. They have discovered that the secretion of IL-1β after inflammasome activation requires membrane permeabilisation, and occurs in parallel with the death of the secreting cell. Thus, in macrophages the release of IL-1β in response to inflammasome activation appears to be a secretory process independent of nonspecific leakage of proteins during cell death. The mechanism of membrane permeabilisation leading to IL-1βrelease is distinct from the unconventional secretory mechanism employed by its structural homologues fibroblast growth factor 2 (FGF2) or IL-1α, a process that involves the formation of membrane pores but does not result in cell death. These discoveries reveal key processes at the initiation of an inflammatory response and deliver new insights into the mechanisms of protein release.

No comment yet.
Scooped by BigField GEG Tech
February 15, 2016 6:36 AM
Scoop.it!

MiR-214 Attenuates Osteogenic Differentiation of Mesenchymal Stem Cells via Targeting FGFR1

BigField GEG Tech's insight:

In this study, the authors used lentiviral vectors which express miR-214 or miR-214 sponge to investigate the effect of miR-214 on osteoblast differentiation of mesenchymal stem cells (MSCs) 

They find that MiR-214 was up-regulated in MSCs of osteoporotic mice and down-regulated during osteoblast differentiation of MSCs. Furthermore, overexpression of miR-214 inhibited osteoblast differentiation of MSCs in vitro, whereas inhibition of miR-214 function promoted this process, evidenced by increased expression of osteoblast-specific genes, alkaline phosphatase (ALP) activity, and matrix mineralization. 

These findings suggest that targeting miR-214 promises to be a potential therapy in treatment of postmenopausal osteoporosis.


www.geg-tech.com/Vectors

No comment yet.
Scooped by BigField GEG Tech
April 6, 2016 10:10 AM
Scoop.it!

Human, pig, and mouse IFITMs partially restrict pseudotyped lentiviral vectors

Human, pig, and mouse IFITMs partially restrict pseudotyped lentiviral vectors | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

Here, the authors demonstrate that a family of proteins with antiviral activity, interferon induced transmembrane proteins (IFITMs), are more highly expressed in the mouse intrapulmonary airways as compared to the nasal airways. Using GP64 and VSV-G pseudotyped FIV, they show that expression of mouse IFITM1, IFITM2, and IFITM3 restricts gene transfer.  Further they show that both the nasal and intrapulmonary airways of IFITM locus knockout mice are more efficiently transduced by GP64-FIV than their heterozygous littermates. The findings are relevant to future pre-clinical and clinical airway gene therapy trials using lentiviral-based vectors.

No comment yet.
Scooped by BigField GEG Tech
March 25, 2016 1:50 PM
Scoop.it!

βcatenin knockdown inhibits the proliferation of human glioma cells in vitro and in vivo

βcatenin knockdown inhibits the proliferation of human glioma cells in vitro and in vivo | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

The aim of the present study was to clarify whether βcatenin was associated with the proliferation and progress of glioma. To do that, scientists have used lentiviral vectors expressing βcatenin short hairpin (sh)RNA. Their results  demonstrated that knockdown of βcatenin expression significantly inhibited the progression of human glioma cancer cells, in vitro and in vivo; thus suggesting that βcatenin silencing may be a novel therapy for the treatment of human glioma.

No comment yet.
Scooped by BigField GEG Tech
March 22, 2016 7:19 AM
Scoop.it!

Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration

Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

Here, the scientists highlight prominent tumorigenic risks of iPSC products, especially when reprogrammed with integrating vectors. Two major underlying mechanisms in iPSC tumorigenicity are residual pluripotent cells and cMYC overload by vector integration.They demonstrate that combined transgene-free (TGF) reprogramming using nonintegrating Sendai viral vectors and enzymatic dissociation allow teratoma-free transplantation of iPSC progeny in the most rigorous mouse model in testing the tumorigenicity of iPSC products.Further long-term safety assessment and improvement in TGF-iPSC specification into a mature b-cell phenotype would lead to customized safe islet replacement therapy for type 1 diabetes.

No comment yet.
Scooped by BigField GEG Tech
March 17, 2016 3:06 AM
Scoop.it!

Design of a titering assay for lentiviral vectors utilizing direct extraction of DNA from transduced cells in microtiter plates

Design of a titering assay for lentiviral vectors utilizing direct extraction of DNA from transduced cells in microtiter plates | Vectorology - GEG Tech top picks | Scoop.it

Click here to edit the content

BigField GEG Tech's insight:

Using lentiviral vector products in clinical applications requires an accurate method for measuring transduction titer.  Here, the authors describe a 96-well transduction titer assay in which DNA extraction is performed in situ in the transduction plate, yielding quantitative recovery of extrachromosomal DNA. Evaluation of the method’s specificity, linear range, and precision demonstrate that it is suitable for use as a lot release assay to support clinical trials with VP02. Finally, the method is compatible with titering both integrating and nonintegrating lentiviral vectors, suggesting that it may be used to evaluate the transduction titer for any lentiviral vector.

No comment yet.
Scooped by BigField GEG Tech
March 14, 2016 7:30 AM
Scoop.it!

siRNA-mediated downregulation of GluN2B in the rostral anterior cingulate cortex attenuates mechanical allodynia and thermal hyperalgesia in a rat model of pain associated with bone cancer.

siRNA-mediated downregulation of GluN2B in the rostral anterior cingulate cortex attenuates mechanical allodynia and thermal hyperalgesia in a rat model of pain associated with bone cancer. | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

The present study used a rat model of bone cancer pain in order to investigate whether lentiviral mediated delivery of small interfering RNAs targeting GluN2B (LVGluN2B) could attenuate pain associated with bone cancer, by selectively decreasing GluN2B expression within the rostral anterior cingulate cortex. The results suggest that GluN2B may be a potential target for RNA interference therapy for the treatment of pain associated with bone cancer. Furthermore, the lentiviral vector delivery strategy may be a promising novel approach for the treatment of bone cancer pain.

 

www.geg-tech.com/Vectors

No comment yet.
Scooped by BigField GEG Tech
March 9, 2016 6:21 AM
Scoop.it!

Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis: Cell Stem Cell

Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis: Cell Stem Cell | Vectorology - GEG Tech top picks | Scoop.it

Click here to edit the content

BigField GEG Tech's insight:

Direct induction of induced hepatocytes (iHeps) from fibroblasts holds potential as a strategy for regenerative medicine but until now has only been shown in culture settings. Here, The authors used a polycistronic lentiviral vector wich expresses OXA3, GATA4, HNF1A, and HNF4A to convert mouse myofibroblasts into cells with a hepatocyte phenotype. This direct in vivo reprogramming approach may open new avenues for the treatment of chronic liver disease.

 

www.geg-tech.com/Vectors

No comment yet.
Scooped by BigField GEG Tech
March 7, 2016 6:26 AM
Scoop.it!

Lentivirus-mediated transfection of chondroitinase ABC gene without the bacterial leader sequence enables long-term secretion of functional chondroitinase ABC in human bone marrow stromal cells 

Lentivirus-mediated transfection of chondroitinase ABC gene without the bacterial leader sequence enables long-term secretion of functional chondroitinase ABC in human bone marrow stromal cells  | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

Here the scientists used a lentiviral vector carrying the ChABC-3F gene without the bacterial leader sequence to test the feasibility of secretion of functional chondroitinase ABC (ChABC), a bacterial enzyme that promotes axonal regeneration after spinal cord injury, from human bone marrow stromal cells (hBMSCs). 

 

www.geg-tech.com/Vectors

No comment yet.
Scooped by BigField GEG Tech
March 3, 2016 6:29 AM
Scoop.it!

MYOD overexpressed equine adipose-derived stem cells enhanced myogenic differentiation potential

MYOD overexpressed equine adipose-derived stem cells enhanced myogenic differentiation potential | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

In this study, the authors used a lentiviral vector to express MYOD and improve the myogenic differentiation potential of equine adipose-derived stem cells (eqASCs). They tested this strategy in vitro and in vivo by transplantation of transduced cells into the tibialis anterior muscles of mice. Their findings suggest that limitations in the treatment of equine muscle disorders could be overcome using ASCs.

 

http://www.geg-tech.com/Portail/index.php/catalog/product/view/id/5809/s/v579014001/

 

No comment yet.
Scooped by BigField GEG Tech
February 25, 2016 2:40 AM
Scoop.it!

“RCL-Pooling Assay”: A Simplified Method for the Detection of Replication-Competent Lentiviruses in Vector Batches Using Sequential Pooling

“RCL-Pooling Assay”: A Simplified Method for the Detection of Replication-Competent Lentiviruses in Vector Batches Using Sequential Pooling | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

Nonreplicative recombinant HIV-1-derived lentiviral vectors (LV) are increasingly used in gene therapy. Before they are used in humans, preparations of LV must undergo extensive quality control testing. Here, the scientists propose a practical optimization of this method using a pairwise pooling strategy enabling easier testing of higher vector inoculum volumes. This optimized “RCL-pooling assay” ameliorates the feasibility of the quality control of large-scale batches of clinical-grade LV while maintaining the same sensitivity.


www.geg-tech.com/Vectors

No comment yet.
Scooped by BigField GEG Tech
February 23, 2016 1:26 PM
Scoop.it!

CRISPR/Cas-mediated gene editing of retinal cells in vivo.

CRISPR/Cas-mediated gene editing of retinal cells in vivo. | Vectorology - GEG Tech top picks | Scoop.it
bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
BigField GEG Tech's insight:

 Here, the authors assessed the feasibility of utilising the adeno-associated virus 2 (AAV2) to deliver CRISPR/Cas for genome modification of retinal cells in vivo.  They observed that AAV2-mediated in vivo delivery of SpCas9 with sgRNA targeting YFP, significantly reduced the number of YFP fluorescent cells of the inner retina of our transgenic mouse model. Overall, they found an 84.0% reduction of YFP-positive cells in YFP-sgRNA infected retinal cells.


www.geg-tech.com/Vectors

No comment yet.
Scooped by BigField GEG Tech
February 22, 2016 1:44 PM
Scoop.it!

Lentiviral-Mediated Netrin-1 Overexpression Improves Motor and Sensory Functions in SCT Rats Associated with SYP and GAP-43 Expressions

Lentiviral-Mediated Netrin-1 Overexpression Improves Motor and Sensory Functions in SCT Rats Associated with SYP and GAP-43 Expressions | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

In this work, the authors used lentiviral vectors to overexpressed or inhibited netrin-1 to study its role in spinal cord injury (SCI). They observed that overexpressing netrin-1 enhanced significantly locomotor function, and reduced thermal and mechanical stimuli in vivo while silencing netrin-1 did not significantly change the situation.These findings therefore pointed that Lv-mediated netrin-1 overexpression could promote motor and sensory functional recoveries following spinal cord transduction, and the underlying mechanisms were associated with SYP and GAP-43 expressions. The present study therefore provided a novel strategy for the treatment of SCI and explained the possible mechanisms for the functional improvement.


www.geg-tech.com/Vectors

No comment yet.
Scooped by BigField GEG Tech
February 16, 2016 6:44 AM
Scoop.it!

U.K. Aims at $15B Gene Therapy Industry

U.K. Aims at $15B Gene Therapy Industry | Vectorology - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

According to Stephen Ward, Ph.D., the U.K. means business when it says it has the goal of building a £10 billion ($15 billion) cell and gene therapy industry in that country.

No comment yet.